Yunkang Group Limited (HKG:2325)
Hong Kong
· Delayed Price · Currency is HKD 0.920
+0.010 (1.10%)
Mar 10, 2026, 11:51 AM HKT
Yunkang Group Market Cap
Yunkang Group has a market cap or net worth of 532.66 million as of March 9, 2026. Its market cap has decreased by -82.55% in one year.
Market Cap
532.66M
Enterprise Value
-200.38M
Revenue
706.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.92
Market Cap Chart
Since May 18, 2022, Yunkang Group's market cap has decreased from 5.21B to 532.66M, a decrease of -89.78%. That is a compound annual growth rate of -45.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 532.66M | -8.08% |
| Dec 31, 2025 | 579.49M | -89.52% |
| Dec 31, 2024 | 5.53B | -25.83% |
| Dec 29, 2023 | 7.46B | -25.55% |
| Dec 30, 2022 | 10.01B | 92.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Biotech Services Holdings | 683.01M |
| Biosino Bio-Technology and Science Incorporation | 785.76M |
| King International Investment | 203.55M |
| Kindstar Globalgene Technology | 1.16B |
| Mega Genomics | 1.57B |
| China Health Group | 138.35M |
| Guanze Medical Information Industry (Holding) | 3.14B |
| Adicon Holdings | 3.59B |